Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes

NCT04831684 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Placebo
DRUG: GET73

Sponsor

Medical University of South Carolina

Collaborators

[object Object]
[object Object]